Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ASX/VIT stock hub

ASX/VIT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/VITis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.5M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/VIT

In the news

Latest news · ASX/VIT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/E30.8

P25 14.2P50 19.2P75 35.1

ROE1.2

P25 -118.7P50 -49.4P75 -1.2

ROIC1.4

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/VIT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

AUD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 33.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	AU0000266801
Last refreshed	2026-05-10
Market cap	AUD 24.5M
Price	AUD 0.04
Price currency	AUD
Sector	Healthcare
Sic	5122
Symbol	asx/VIT
Website	https://vitura.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.2%
EV Earnings	42.44x
EV/EBIT	13.99x
EV/EBITDA	12.16x
EV/FCF	24.1x
EV/Sales	0.26x
FCF yield	5.63%
P/B ratio	0.54x
P/E ratio	30.81x
P/S ratio	0.19x
PE Ratio10 Y	22.25x
PE Ratio3 Y	24.42x
PE Ratio5 Y	21.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.84%
EBITDA Margin	1.49%
FCF margin	1.07%
Gross margin	25.01%
Gross Profit	AUD 32.3M
Gross Profit Growth	-4.23%
Gross Profit Growth Q	-8.48%
Gross Profit Growth3 Y	-1.88%
Gross Profit Growth5 Y	-4.02%
Net Income	AUD 784,131
Net Income Growth	-59.69%
Net Income Growth Years	0%
Net Income Growth3 Y	-39.34%
Net Income Growth5 Y	-43.66%
Pretax Margin	1.19%
Profit Margin	0.61%
Profitable Years	4
ROA	2.01
Roa5y	13.95
ROCE	4.49
ROE	1.15
Roe5y	23.47
ROIC	1.4
Roic5y	48.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.59%
Cagr3y	-51.57%
Cagr5y	-17.64%
EPS Growth	-63.75
EPS Growth Years	0
EPS Growth3 Y	-42.02
EPS Growth5 Y	-45.15
FCF Growth3 Y	-40.84%
FCF Growth5 Y	-30.92%
OCF Growth	2,401.89%
OCF Growth3 Y	-40.45%
OCF Growth5 Y	-31.38%
Revenue Growth	2.11x
Revenue Growth Q	8.3x
Revenue Growth Quarters	1x
Revenue Growth Years	5x
Revenue Growth3 Y	1.42x
Revenue Growth5 Y	1.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 1.75
Assets	AUD 76.9M
Cash	AUD 6.1M
Current Assets	AUD 27.1M
Current Liabilities	AUD 23.9M
Debt	AUD 15.6M
Debt EBITDA	AUD 5.7
Debt Equity	AUD 0.34
Debt FCF	AUD 11.3
Equity	AUD 45.4M
Interest Coverage	2.26
Liabilities	AUD 31.5M
Long Term Assets	AUD 49.7M
Long Term Liabilities	AUD 7.6M
Net Cash	AUD -9.5M
Net Cash By Market Cap	AUD -38.76
Net Debt EBITDA	AUD 4.93
Net Debt Equity	AUD 0.21
Net Debt FCF	AUD 6.88
Tangible Book Value	AUD 5.9M
Tangible Book Value Per Share	AUD 0.01
WACC	-1.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	13.86
Net Working Capital	AUD 5.4M
Quick ratio	0.79
Working Capital	AUD 3.2M
Working Capital Turnover	AUD 21.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.19%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	AUD 0
Dividend Years	1
Dividend Yield	5.41%
Last Dividend	AUD 0
Payout Ratio	164.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.57%
200-day SMA	0.06
3Y total return	-88.65%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-62.09%
All Time High	1.04
All Time High Change	-96.44%
All Time High Date	2022-10-19
All Time Low	0.04
All Time Low Change	5.71%
All Time Low Date	2026-04-16
ATR	0
Beta	-1.4
Beta1y	-0.27
Beta2y	0.62
Ch YTD	-39.34
High	0.04
High52	0.08
High52 Date	2025-08-06
High52ch	-50.67%
Low	0.04
Low52	0.04
Low52 Date	2026-04-20
Low52ch	5.71%
Ma50ch	-5.61%
Price vs 200-day SMA	-35.54%
RSI	44.66
RSI Monthly	33.02
RSI Weekly	30.92
Sharpe ratio	-1.14x
Sortino ratio	-1.42
Total Return	-7.78%
Tr YTD	-39.34
Tr1m	-7.5%
Tr1w	-5.13%
Tr3m	-30.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 2.4M
Operating Income Growth	-54.62
Operating Income Growth3 Y	-21.23
Operating Income Growth5 Y	-34.59
Operating margin	1.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	228,323,006%
Net Borrowing	-1,680,105
Shares Insiders	34.7%
Shares Institutions	1.28%
Shares Out	662,741,837
Shares Qo Q	3.1%
Shares Yo Y	13.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 1.4M
Average Volume	401,734.5x
Bv Per Share	0.07
CAPEX	AUD -96,699
Ch1m	-7.5
Ch1w	-5.13
Ch1y	-47.14
Ch3m	-30.19
Ch3y	-89.28
Ch5y	-64.76
Ch6m	-40.32
Change	0%
Change From Open	0
Close	0.04
Days Gap	0
Depreciation Amortization	-450,710
Dollar Volume	7,115.1
Earnings Date	2026-05-26
EBIT	AUD 2.4M
EBITDA	AUD 1.9M
EPS	AUD 0
F Score	6
FCF	AUD 1.4M
FCF EV Yield	4.15x
FCF Per Share	AUD 0
Financing CF	2,176,611
Fiscal Year End	June
Founded	2,018
Goodwill	22,195,483
Graham Number	0.04336
Graham Upside	17.19
Income Tax	AUD 1M
Investing CF	-4,950,832
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Lynch Fair Value	AUD 0.01
Lynch Upside	-83.76
Ma150	0.05
Ma150ch	-31.35%
Ma20	0.04
Ma20ch	-1.07%
Net CF	-1,296,630
Next Earnings Date	2026-05-26
Open	0.04
P FCF Ratio	17.76
P OCF Ratio	16.6
Payment Date	2025-09-30
Position In Range	100
Ppne	2,870,372
Price Date	2026-05-08
Price EBITDA	AUD 12.72
Ptbv Ratio	4.18
Relative Volume	0.49x
Revenue	129,235,490x
SBC By Revenue	0x
Share Based Comp	1,487
Tax By Revenue	0.81x
Tax Rate	67.78%
Tr6m	-40.32%
Volume	192,300
Z Score	2.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ASX/VIT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.4%

$0.00 annual per share

Payout ratio

+165.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-7.8%

Dividend yield + buyback yield combined

Performance

ASX/VIT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/VIT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.3%

Share of float held by funds and institutions

Insider ownership

+34.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.2%

Negative means the company is buying back shares.

Technical

ASX/VIT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-35.5%

50/200-day relationship not available

Beta (5Y)

-1.40

Less volatile than the market

Sharpe ratio

-1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/VIT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/VIT stock rating?

asx/VIT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/VIT analysis?

The full report lives at /stocks/asx/VIT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/VIT?

The latest report frames asx/VIT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/VIT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.